Industry: Medical Devices & Consumables
Published Date: 2026-01-08
Pages: 121 Pages
Report ld: 5588251
Request Sample
Customized Report
Human NK Cell Isolation Kit Market Size(US$)

CAGR 2026-2032
6.5%
Market Size,2032
USD 497
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Human NK Cell Isolation Kit market was valued at US$ 322 million in 2025 and is anticipated to reach US$ 497 million by 2032, at a CAGR of 6.5% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Human NK Cell Isolation Kit competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The Human NK Cell Isolation Kit is designed to magnetically isolate NK cells from a complex immune cell population. The kit is optimized for the isolation of CD56+CD3- cells from normal human peripheral blood mononuclear cells (PBMCs). The cells are incubated with a cocktail of antibodies and then bound to magnetic beads. They are then placed on a magnet for quick and easy separation. When placed on the magnet, non-NK cells will be fixed to the side of the tube, while NK cells will remain in suspension and can be easily removed for downstream applications.
The North American market for Human NK Cell Isolation Kit is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Human NK Cell Isolation Kit is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Human NK Cell Isolation Kit include BPS Bioscience, Miltenyi Biotec, Novus Biologicals, STEMCELL Technologies, Thermo Fisher Scientific, RWD, Xinxie Biotechnology, Jinzhun Biotechnology, R&D Systems, BioLegend, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Human NK Cell Isolation Kit market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Human NK Cell Isolation Kit. The Human NK Cell Isolation Kit market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Human NK Cell Isolation Kit market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Human NK Cell Isolation Kit manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Human NK Cell Isolation Kit manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Human NK Cell Isolation Kit sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Human NK Cell Isolation Kit Market Overview
1.1 Product Definition
1.2 Human NK Cell Isolation Kit by Type
1.2.1 Global Human NK Cell Isolation Kit Market Value by Type: 2025 vs 2032
1.2.2 1 x 10^8 Cells
1.2.3 1 x 10^9 Cells
1.2.4 Other
1.3 Human NK Cell Isolation Kit by Application
1.3.1 Global Human NK Cell Isolation Kit Market Value by Application: 2025 vs 2032
1.3.2 Research Institute
1.3.3 School
1.3.4 Other
1.4 Global Human NK Cell Isolation Kit Market Size Estimates and Forecasts
1.4.1 Global Human NK Cell Isolation Kit Revenue 2021–2032
1.4.2 Global Human NK Cell Isolation Kit Sales 2021–2032
1.4.3 Global Human NK Cell Isolation Kit Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Human NK Cell Isolation Kit Market Competition by Manufacturers
2.1 Global Human NK Cell Isolation Kit Sales Market Share by Manufacturers (2021–2026)
2.2 Global Human NK Cell Isolation Kit Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Human NK Cell Isolation Kit Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Human NK Cell Isolation Kit, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Human NK Cell Isolation Kit, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Human NK Cell Isolation Kit, Product Types and Applications
2.7 Global Key Manufacturers of Human NK Cell Isolation Kit, Date of Entry into the Industry
2.8 Global Human NK Cell Isolation Kit Market Competitive Situation and Trends
2.8.1 Global Human NK Cell Isolation Kit Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Human NK Cell Isolation Kit Players Market Share by Revenue
2.8.3 Global Human NK Cell Isolation Kit Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human NK Cell Isolation Kit Market Scenario by Region
3.1 Global Human NK Cell Isolation Kit Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Human NK Cell Isolation Kit Sales by Region: 2021–2032
3.2.1 Global Human NK Cell Isolation Kit Sales by Region: 2021–2026
3.2.2 Global Human NK Cell Isolation Kit Sales by Region: 2027–2032
3.3 Global Human NK Cell Isolation Kit Revenue by Region: 2021–2032
3.3.1 Global Human NK Cell Isolation Kit Revenue by Region: 2021–2026
3.3.2 Global Human NK Cell Isolation Kit Revenue by Region: 2027–2032
3.4 North America Human NK Cell Isolation Kit Market Facts & Figures by Country
3.4.1 North America Human NK Cell Isolation Kit Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Human NK Cell Isolation Kit Sales by Country (2021–2032)
3.4.3 North America Human NK Cell Isolation Kit Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human NK Cell Isolation Kit Market Facts & Figures by Country
3.5.1 Europe Human NK Cell Isolation Kit Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Human NK Cell Isolation Kit Sales by Country (2021–2032)
3.5.3 Europe Human NK Cell Isolation Kit Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human NK Cell Isolation Kit Market Facts & Figures by Region
3.6.1 Asia Pacific Human NK Cell Isolation Kit Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Human NK Cell Isolation Kit Sales by Region (2021–2032)
3.6.3 Asia Pacific Human NK Cell Isolation Kit Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Human NK Cell Isolation Kit Market Facts & Figures by Country
3.7.1 Latin America Human NK Cell Isolation Kit Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Human NK Cell Isolation Kit Sales by Country (2021–2032)
3.7.3 Latin America Human NK Cell Isolation Kit Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Human NK Cell Isolation Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa Human NK Cell Isolation Kit Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Human NK Cell Isolation Kit Sales by Country (2021–2032)
3.8.3 Middle East and Africa Human NK Cell Isolation Kit Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human NK Cell Isolation Kit Sales by Type (2021–2032)
4.1.1 Global Human NK Cell Isolation Kit Sales by Type (2021–2026)
4.1.2 Global Human NK Cell Isolation Kit Sales by Type (2027–2032)
4.1.3 Global Human NK Cell Isolation Kit Sales Market Share by Type (2021–2032)
4.2 Global Human NK Cell Isolation Kit Revenue by Type (2021–2032)
4.2.1 Global Human NK Cell Isolation Kit Revenue by Type (2021–2026)
4.2.2 Global Human NK Cell Isolation Kit Revenue by Type (2027–2032)
4.2.3 Global Human NK Cell Isolation Kit Revenue Market Share by Type (2021–2032)
4.3 Global Human NK Cell Isolation Kit Price by Type (2021–2032)
5 Segment by Application
5.1 Global Human NK Cell Isolation Kit Sales by Application (2021–2032)
5.1.1 Global Human NK Cell Isolation Kit Sales by Application (2021–2026)
5.1.2 Global Human NK Cell Isolation Kit Sales by Application (2027–2032)
5.1.3 Global Human NK Cell Isolation Kit Sales Market Share by Application (2021–2032)
5.2 Global Human NK Cell Isolation Kit Revenue by Application (2021–2032)
5.2.1 Global Human NK Cell Isolation Kit Revenue by Application (2021–2026)
5.2.2 Global Human NK Cell Isolation Kit Revenue by Application (2027–2032)
5.2.3 Global Human NK Cell Isolation Kit Revenue Market Share by Application (2021–2032)
5.3 Global Human NK Cell Isolation Kit Price by Application (2021–2032)
6 Key Companies Profiled
6.1 BPS Bioscience
6.1.1 BPS Bioscience Company Information
6.1.2 BPS Bioscience Description and Business Overview
6.1.3 BPS Bioscience Human NK Cell Isolation Kit Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 BPS Bioscience Human NK Cell Isolation Kit Product Portfolio
6.1.5 BPS Bioscience Recent Developments/Updates
6.2 Miltenyi Biotec
6.2.1 Miltenyi Biotec Company Information
6.2.2 Miltenyi Biotec Description and Business Overview
6.2.3 Miltenyi Biotec Human NK Cell Isolation Kit Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Miltenyi Biotec Human NK Cell Isolation Kit Product Portfolio
6.2.5 Miltenyi Biotec Recent Developments/Updates
6.3 Novus Biologicals
6.3.1 Novus Biologicals Company Information
6.3.2 Novus Biologicals Description and Business Overview
6.3.3 Novus Biologicals Human NK Cell Isolation Kit Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Novus Biologicals Human NK Cell Isolation Kit Product Portfolio
6.3.5 Novus Biologicals Recent Developments/Updates
6.4 STEMCELL Technologies
6.4.1 STEMCELL Technologies Company Information
6.4.2 STEMCELL Technologies Description and Business Overview
6.4.3 STEMCELL Technologies Human NK Cell Isolation Kit Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 STEMCELL Technologies Human NK Cell Isolation Kit Product Portfolio
6.4.5 STEMCELL Technologies Recent Developments/Updates
6.5 Thermo Fisher Scientific
6.5.1 Thermo Fisher Scientific Company Information
6.5.2 Thermo Fisher Scientific Description and Business Overview
6.5.3 Thermo Fisher Scientific Human NK Cell Isolation Kit Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Thermo Fisher Scientific Human NK Cell Isolation Kit Product Portfolio
6.5.5 Thermo Fisher Scientific Recent Developments/Updates
6.6 RWD
6.6.1 RWD Company Information
6.6.2 RWD Description and Business Overview
6.6.3 RWD Human NK Cell Isolation Kit Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 RWD Human NK Cell Isolation Kit Product Portfolio
6.6.5 RWD Recent Developments/Updates
6.7 Xinxie Biotechnology
6.7.1 Xinxie Biotechnology Company Information
6.7.2 Xinxie Biotechnology Description and Business Overview
6.7.3 Xinxie Biotechnology Human NK Cell Isolation Kit Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Xinxie Biotechnology Human NK Cell Isolation Kit Product Portfolio
6.7.5 Xinxie Biotechnology Recent Developments/Updates
6.8 Jinzhun Biotechnology
6.8.1 Jinzhun Biotechnology Company Information
6.8.2 Jinzhun Biotechnology Description and Business Overview
6.8.3 Jinzhun Biotechnology Human NK Cell Isolation Kit Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Jinzhun Biotechnology Human NK Cell Isolation Kit Product Portfolio
6.8.5 Jinzhun Biotechnology Recent Developments/Updates
6.9 R&D Systems
6.9.1 R&D Systems Company Information
6.9.2 R&D Systems Description and Business Overview
6.9.3 R&D Systems Human NK Cell Isolation Kit Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 R&D Systems Human NK Cell Isolation Kit Product Portfolio
6.9.5 R&D Systems Recent Developments/Updates
6.10 BioLegend
6.10.1 BioLegend Company Information
6.10.2 BioLegend Description and Business Overview
6.10.3 BioLegend Human NK Cell Isolation Kit Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 BioLegend Human NK Cell Isolation Kit Product Portfolio
6.10.5 BioLegend Recent Developments/Updates
6.11 Proteintech Group
6.11.1 Proteintech Group Company Information
6.11.2 Proteintech Group Description and Business Overview
6.11.3 Proteintech Group Human NK Cell Isolation Kit Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Proteintech Group Human NK Cell Isolation Kit Product Portfolio
6.11.5 Proteintech Group Recent Developments/Updates
6.12 Stemery
6.12.1 Stemery Company Information
6.12.2 Stemery Description and Business Overview
6.12.3 Stemery Human NK Cell Isolation Kit Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Stemery Human NK Cell Isolation Kit Product Portfolio
6.12.5 Stemery Recent Developments/Updates
6.13 Creative Bioarray
6.13.1 Creative Bioarray Company Information
6.13.2 Creative Bioarray Description and Business Overview
6.13.3 Creative Bioarray Human NK Cell Isolation Kit Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Creative Bioarray Human NK Cell Isolation Kit Product Portfolio
6.13.5 Creative Bioarray Recent Developments/Updates
6.14 LubioScience
6.14.1 LubioScience Company Information
6.14.2 LubioScience Description and Business Overview
6.14.3 LubioScience Human NK Cell Isolation Kit Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 LubioScience Human NK Cell Isolation Kit Product Portfolio
6.14.5 LubioScience Recent Developments/Updates
6.15 Immocell
6.15.1 Immocell Company Information
6.15.2 Immocell Description and Business Overview
6.15.3 Immocell Human NK Cell Isolation Kit Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Immocell Human NK Cell Isolation Kit Product Portfolio
6.15.5 Immocell Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human NK Cell Isolation Kit Industry Chain Analysis
7.2 Human NK Cell Isolation Kit Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human NK Cell Isolation Kit Production Mode & Process Analysis
7.4 Human NK Cell Isolation Kit Sales and Marketing
7.4.1 Human NK Cell Isolation Kit Sales Channels
7.4.2 Human NK Cell Isolation Kit Distributors
7.5 Human NK Cell Isolation Kit Customer Analysis
8 Human NK Cell Isolation Kit Market Dynamics
8.1 Human NK Cell Isolation Kit Industry Trends
8.2 Human NK Cell Isolation Kit Market Drivers
8.3 Human NK Cell Isolation Kit Market Challenges
8.4 Human NK Cell Isolation Kit Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Human NK Cell Isolation Kit market is projected to grow from US$ 322 million in 2025 to US$ 497 million by 2032, at a CAGR of 6.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 159
USD 4900.00
(Single User License)
The global Human NK Cell Isolation Kit market size was US$ 322 million in 2025 and is forecast to reach a readjusted size of US$ 497 million by 2032 with a CAGR of 6.5% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 91
USD 4250.00
(Single User License)
The global market for Human NK Cell Isolation Kit was estimated to be worth US$ 322 million in 2025 and is projected to reach US$ 497 million, growing at a CAGR of 6.5% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 115
USD 3950.00
(Single User License)
The global Human NK Cell Isolation Kit market size was US$ 304 million in 2024 and is forecast to a readjusted size of US$ 470 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 100
USD 4250.00
(Single User License)
The global Human NK Cell Isolation Kit market is projected to grow from US$ 304 million in 2024 to US$ 470 million by 2031, at a CAGR of 6.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 153
USD 4900.00
(Single User License)
The global market for Human NK Cell Isolation Kit was estimated to be worth US$ 304 million in 2024 and is forecast to a readjusted size of US$ 470 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 123
USD 3950.00
(Single User License)
The global market for Human NK Cell Isolation Kit was valued at US$ 304 million in the year 2024 and is projected to reach a revised size of US$ 470 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Published Date: 2025-03-10
Pages: 97
USD 2900.00
(Single User License)
The global Human NK Cell Isolation Kit revenue was US$ 282 million in 2023 and is forecast to a readjusted size of US$ 444 million by 2030 with a CAGR of 6.5% during the review period (2024-2030).
Published Date: 2025-01-01
Pages: 140
USD 4350.00
(Single User License)
Valued at US$ 304 million in 2024, the global Human NK Cell Isolation Kit market is forecast to reach US$ 444 million by 2030, at a CAGR of 6.5% during the forecast period.
Published Date: 2025-01-01
Pages: 161
USD 4900.00
(Single User License)
The global market for Human NK Cell Isolation Kit was estimated to be worth US$ 282 million in 2023 and is forecast to a readjusted size of US$ 444 million by 2030 with a CAGR of 6.5% during the forecast period 2024-2030.
Published Date: 2025-01-01
Pages: 111
USD 3950.00
(Single User License)
The global Human NK Cell Isolation Kit market is projected to grow from US$ 322 million in 2025 to US$ 497 million by 2032, at a CAGR of 6.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 159
The global Human NK Cell Isolation Kit market size was US$ 322 million in 2025 and is forecast to reach a readjusted size of US$ 497 million by 2032 with a CAGR of 6.5% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 91
The global market for Human NK Cell Isolation Kit was estimated to be worth US$ 322 million in 2025 and is projected to reach US$ 497 million, growing at a CAGR of 6.5% from 2026 to 2032.
Published: 2026-01-19
Pages: 115
The global Human NK Cell Isolation Kit market size was US$ 304 million in 2024 and is forecast to a readjusted size of US$ 470 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 100
The global Human NK Cell Isolation Kit market is projected to grow from US$ 304 million in 2024 to US$ 470 million by 2031, at a CAGR of 6.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 153
The global market for Human NK Cell Isolation Kit was estimated to be worth US$ 304 million in 2024 and is forecast to a readjusted size of US$ 470 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 123
The global market for Human NK Cell Isolation Kit was valued at US$ 304 million in the year 2024 and is projected to reach a revised size of US$ 470 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Published: 2025-03-10
Pages: 97
The global Human NK Cell Isolation Kit revenue was US$ 282 million in 2023 and is forecast to a readjusted size of US$ 444 million by 2030 with a CAGR of 6.5% during the review period (2024-2030).
Published: 2025-01-01
Pages: 140
Valued at US$ 304 million in 2024, the global Human NK Cell Isolation Kit market is forecast to reach US$ 444 million by 2030, at a CAGR of 6.5% during the forecast period.
Published: 2025-01-01
Pages: 161
The global market for Human NK Cell Isolation Kit was estimated to be worth US$ 282 million in 2023 and is forecast to a readjusted size of US$ 444 million by 2030 with a CAGR of 6.5% during the forecast period 2024-2030.
Published: 2025-01-01
Pages: 111
REPORT COVERAGE
DESCRIPTION
MARKET SEGMENTATION
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now